Symbols

VMD

Viemed Healthcare·NASDAQ

--(--)

VMD fundamentals

VMD Q4 2025 Earnings

Viemed Healthcare (VMD) released its earnings on Mar 4, 2026: revenue was 76.18M (YoY +25.51%), missed estimates; EPS was 0.14 (YoY +40.00%), beat estimates.

Revenue / YoY

76.18M

+25.51%

EPS / YoY

0.14

+40.00%

Report date

Mar 4, 2026

VMD Earnings Call Summary for Q4,2025

Revenue Growth: 21% YoY to $270.3M, with sleep therapy up 62% and maternal health contributing $9M.
Free Cash Flow: Doubled to $28.1M, enabling $5M share buyback program.
2026 Outlook: $310-320M revenue (+17%), stable margins, and maternal health as fastest-growing segment.
Risk Management: NCD transition affecting ventilator growth, but 100% Medicare appeal success rate.
Strategic Moves: Technology investment, disciplined workforce expansion, and accretive M&A focus.

Earnings

EPS

Revenue

Revenue & Expenses

VMD has released its 2025 Q4 earnings report, with revenue of 76.18M, reflecting a YoY change of 25.51%, and net profit of 5.82M, showing a YoY change of 31.46%. The Sankey diagram below clearly presents VMD's revenue sources and cost distribution.

Key Indicators

Viemed Healthcare (VMD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Viemed Healthcare (VMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Viemed Healthcare (VMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Viemed Healthcare (VMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown